Remove Chemotherapy Remove Immunization Remove Labelling
article thumbnail

US FDA grants approval for AstraZeneca’s lung cancer therapy

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for AstraZeneca ’s Imfinzi (durvalumab) plus Imjudo (tremelimumab) and platinum-based chemotherapy to treat Stage IV (metastatic) non-small cell lung cancer (NSCLC) in adults.

FDA 52
article thumbnail

Tuoyi to transform treatment of recurrent/metastatic nasopharyngeal carcinoma

Pharmaceutical Technology

Patients in the US and EU with recurrent or metastatic nasopharyngeal carcinoma (NPC), a subtype of head and neck squamous cell carcinoma (HNSCC), are mostly treated with a combination of chemotherapy agents in the frontline setting, such as cisplatin + gemcitabine. months for the chemotherapy arm (hazard ratio [HR]: 0.52).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Does Ozempic cause yeast infections?

The Checkup by Singlecare

It is also sometimes prescribed off-label (for a non-FDA-approved use) for weight loss. Weakened immune system : A weakened immune system due to certain conditions like HIV , or from taking certain medicines such as steroids, chemotherapy, or transplant medicines, can increase the risk of yeast infections.

article thumbnail

Immunocore gets EU nod for TCR cancer therapy Kimmtrak

pharmaphorum

Kimmtrak (tebentafusp) has been cleared to for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma (mUM), mirroring its label in the US. GlobalData analyst Dr Sakis Palioras said in a recent research not that Kimmtrak’s 5.7 ” Image by Pexels from Pixabay .

article thumbnail

Immunocore claims first-ever FDA approval for TCR cancer therapy

pharmaphorum

“Every year in the US, hundreds of people are diagnosed with metastatic uveal melanoma who, until now, had no approved treatment options,” said Immunocore chief executive Bahija Jallal.

FDA 124
article thumbnail

Who should not take probiotics?

The Checkup by Singlecare

A healthy gut biome is crucial to your immune system and regulates proper digestion, bowel movements, and other bodily functions. People with compromised immune systems. Anyone with food allergies should thoroughly review the label, research the company, and consult their allergist or healthcare provider before taking probiotics.

article thumbnail

Roche nabs breakthrough tag for TIGIT cancer immunotherapy

pharmaphorum

Like PD-L1, TIGIT is thought to act as a molecular brake that stops T cells from attacking tumours, and tiragolumab is currently leading the pack among drugs targeting the immune checkpoint.